SMS Pharmaceuticals has sold and transferred the facility situated at Unit-VI, Plot No. 28, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam in state of Andhra Pradesh to Mylan Laboratories (Mylan). The company has taken this step as per Business Transfer Agreement entered with Mylan on October 16, 2012.
Last year in October, the company had considered and approved the sale consideration for Unit -VI at Rs 173.00 crore for which it had identified and finalized Mylan as buyer out of the proposals received. The company had already received its board’s approval for the same at a meeting held on August 18, 2012.
SMS Pharmaceuticals is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates. The company has six manufacturing facilities and two R&D facilities located in Andhra Pradesh.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1903.00 |
| Dr. Reddys Labs. | 1353.75 |
| Cipla | 1452.35 |
| Zydus Lifesciences | 1152.90 |
| Lupin | 2489.85 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: